The Supreme Cannabis Stock EBITDA
The Supreme Cannabis fundamentals help investors to digest information that contributes to Supreme Cannabis' financial success or failures. It also enables traders to predict the movement of Supreme OTC Stock. The fundamental analysis module provides a way to measure Supreme Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Supreme Cannabis otc stock.
Supreme |
The Supreme Cannabis OTC Stock EBITDA Analysis
Supreme Cannabis' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Supreme Cannabis EBITDA | (47.12 M) |
Most of Supreme Cannabis' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Supreme Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, The Supreme Cannabis reported earnings before interest,tax, depreciation and amortization of (47.12 Million). This is 105.37% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 101.21% higher than that of the company.
Supreme EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Supreme Cannabis' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Supreme Cannabis could also be used in its relative valuation, which is a method of valuing Supreme Cannabis by comparing valuation metrics of similar companies.Supreme Cannabis is currently under evaluation in ebitda category among related companies.
Supreme Fundamentals
| Return On Equity | -7.85 | |||
| Return On Asset | -9.9 | |||
| Profit Margin | (28.91) % | |||
| Operating Margin | (97.08) % | |||
| Current Valuation | 215.62 M | |||
| Shares Outstanding | 762.93 M | |||
| Shares Owned By Insiders | 0.31 % | |||
| Shares Owned By Institutions | 19.63 % | |||
| Price To Earning | (9.70) X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 3.84 X | |||
| Revenue | 53.29 M | |||
| Gross Profit | 5.48 M | |||
| EBITDA | (47.12 M) | |||
| Net Income | (15.4 M) | |||
| Cash And Equivalents | 65.55 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 76.37 M | |||
| Debt To Equity | 0.33 % | |||
| Current Ratio | 1.62 X | |||
| Book Value Per Share | 0.31 X | |||
| Cash Flow From Operations | (14.96 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 400 | |||
| Beta | 2.22 | |||
| Market Capitalization | 204.47 M | |||
| Z Score | 1.2 |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Supreme OTC Stock
If you are still planning to invest in Supreme Cannabis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Supreme Cannabis' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |